Corpus ID: 17894115

Dopamine Agonists in Parkinson Disease : Special Focus on Pramipexole

@inproceedings{Zesiewicz2008DopamineAI,
  title={Dopamine Agonists in Parkinson Disease : Special Focus on Pramipexole},
  author={T. Zesiewicz},
  year={2008}
}
S8 CONSULTANT SEPTEMBER 2008 (SUPPLEMENT) ABSTRACT: Dopamine receptor agonists have played an important role in antiparkinsonian therapy since the first ergoline derivative was introduced in 1974. The non-ergoline dopamine agonists, developed later to provide the benefits of the ergolines with fewer side effects, are currently used as both monotherapy and as adjunctive therapy to treat symptoms of Parkinson disease (PD), to postpone the onset of levodopa therapy, to delay the development and… Expand
1 Citations

Figures from this paper

References

SHOWING 1-10 OF 122 REFERENCES
Rotigotine for the treatment of Parkinson’s disease
Dopamine agonists in the treatment of Parkinson’s disease
...
1
2
3
4
5
...